Cite

HARVARD Citation

    Aravind, P. et al. (2017). Long-term Outcome of HER2-positive Early Breast Cancer Patients in the Trastuzumab Era: a Single Centre Experience. Clinical oncology. 29 (6), pp. e97-. [Online]. 
  
Back to record